[1]
“Evaluation of HBV-DNA Monitoring after Completion of Chemotherapy using a PDCA Cycle following Introduction of a Support System Provided by a Multidisciplinary Team of Quality Management in Cancer Medicine”, J. Can. Res. Updates, vol. 14, pp. 218–223, Dec. 2025, doi: 10.30683/1929-2279.2025.14.23.